作者
A Pieter Kappetein, Stuart J Head, Philippe Généreux, Nicolo Piazza, Nicolas M Van Mieghem, Eugene H Blackstone, Thomas G Brott, David J Cohen, Donald E Cutlip, Gerrit-Anne van Es, Rebecca T Hahn, Ajay J Kirtane, Mitchell W Krucoff, Susheel Kodali, Michael J Mack, Roxana Mehran, Josep Rodés-Cabau, Pascal Vranckx, John G Webb, Stephan Windecker, Patrick W Serruys, Martin B Leon
发表日期
2012/10/9
来源
Journal of the American College of Cardiology
卷号
60
期号
15
页码范围
1438-1454
出版商
American College of Cardiology Foundation
简介
Objectives
The aim of the current Valve Academic Research Consortium (VARC)-2 initiative was to revisit the selection and definitions of transcatheter aortic valve implantation (TAVI) clinical endpoints to make them more suitable to the present and future needs of clinical trials. In addition, this document is intended to expand the understanding of patient risk stratification and case selection.
Background
A recent study confirmed that VARC definitions have already been incorporated into clinical and research practice and represent a new standard for consistency in reporting clinical outcomes of patients with symptomatic severe aortic stenosis (AS) undergoing TAVI. However, as the clinical experience with this technology has matured and expanded, certain definitions have become unsuitable or ambiguous.
Methods and Results
Two in-person meetings (held in September 2011 in Washington, DC, USA, and in …
学术搜索中的文章
AP Kappetein, SJ Head, P Généreux, N Piazza… - Journal of the American College of Cardiology, 2012